Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition:   Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention:   Drug: LUM001Sponsor:   ShireRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials

Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition:   Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention:   Drug: LUM001Sponsors:   Lumena Pharmaceuticals, Inc.;   Childhood Liver Disease Research and Education NetworkRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials

Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition:   Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention:   Drug: LUM001Sponsor:   ShireRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials

The Metabolic Profile of Obstetric Cholestasis
Condition:   Cholestasis of PregnancyIntervention:   Sponsor:   Imperial College LondonRecruiting - verified September 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2011 Category: Research Source Type: clinical trials